TY - JOUR
T1 - Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels
T2 - A comparative serological study
AU - Reusken, Chantal B.E.M.
AU - Haagmans, Bart L.
AU - Müller, Marcel A.
AU - Gutierrez, Carlos
AU - Godeke, Gert Jan
AU - Meyer, Benjamin
AU - Muth, Doreen
AU - Raj, V. Stalin
AU - Vries, Laura Smits De
AU - Corman, Victor M.
AU - Drexler, Jan Felix
AU - Smits, Saskia L.
AU - El Tahir, Yasmin E.
AU - De Sousa, Rita
AU - van Beek, Janko
AU - Nowotny, Norbert
AU - van Maanen, Kees
AU - Hidalgo-Hermoso, Ezequiel
AU - Bosch, Berend Jan
AU - Rottier, Peter
AU - Osterhaus, Albert
AU - Gortázar-Schmidt, Christian
AU - Drosten, Christian
AU - Koopmans, Marion P.G.
N1 - Funding Information:
We thank Prof MC Horzinek for helpful suggestions. RDS was funded by the European Public Health Training Program (Euphem), ECDC, Stockholm, Sweden. Contributions to the study were funded through the European Union FP7 projects EMPERIE (contract number 223498; to BLH, SLS, AO, CD) and ANTIGONE (contract number 278976; to CG, CD, MPGK, AO). Work in Bonn was also funded by Deutsche Forschungsgemeinschaft (DFG grant DR772/3-1 to CD ).
PY - 2013/10
Y1 - 2013/10
N2 - Background: A new betacoronavirus-Middle East respiratory syndrome coronavirus (MERS-CoV)-has been identified in patients with severe acute respiratory infection. Although related viruses infect bats, molecular clock analyses have been unable to identify direct ancestors of MERS-CoV. Anecdotal exposure histories suggest that patients had been in contact with dromedary camels or goats. We investigated possible animal reservoirs of MERS-CoV by assessing specific serum antibodies in livestock. Methods: We took sera from animals in the Middle East (Oman) and from elsewhere (Spain, Netherlands, Chile). Cattle (n=80), sheep (n=40), goats (n=40), dromedary camels (n=155), and various other camelid species (n=34) were tested for specific serum IgG by protein microarray using the receptor-binding S1 subunits of spike proteins of MERS-CoV, severe acute respiratory syndrome coronavirus, and human coronavirus OC43. Results were confirmed by virus neutralisation tests for MERS-CoV and bovine coronavirus. Findings: 50 of 50 (100%) sera from Omani camels and 15 of 105 (14%) from Spanish camels had protein-specific antibodies against MERS-CoV spike. Sera from European sheep, goats, cattle, and other camelids had no such antibodies. MERS-CoV neutralising antibody titres varied between 1/320 and 1/2560 for the Omani camel sera and between 1/20 and 1/320 for the Spanish camel sera. There was no evidence for cross-neutralisation by bovine coronavirus antibodies. Interpretation: MERS-CoV or a related virus has infected camel populations. Both titres and seroprevalences in sera from different locations in Oman suggest widespread infection. Funding: European Union, European Centre For Disease Prevention and Control, Deutsche Forschungsgemeinschaft.
AB - Background: A new betacoronavirus-Middle East respiratory syndrome coronavirus (MERS-CoV)-has been identified in patients with severe acute respiratory infection. Although related viruses infect bats, molecular clock analyses have been unable to identify direct ancestors of MERS-CoV. Anecdotal exposure histories suggest that patients had been in contact with dromedary camels or goats. We investigated possible animal reservoirs of MERS-CoV by assessing specific serum antibodies in livestock. Methods: We took sera from animals in the Middle East (Oman) and from elsewhere (Spain, Netherlands, Chile). Cattle (n=80), sheep (n=40), goats (n=40), dromedary camels (n=155), and various other camelid species (n=34) were tested for specific serum IgG by protein microarray using the receptor-binding S1 subunits of spike proteins of MERS-CoV, severe acute respiratory syndrome coronavirus, and human coronavirus OC43. Results were confirmed by virus neutralisation tests for MERS-CoV and bovine coronavirus. Findings: 50 of 50 (100%) sera from Omani camels and 15 of 105 (14%) from Spanish camels had protein-specific antibodies against MERS-CoV spike. Sera from European sheep, goats, cattle, and other camelids had no such antibodies. MERS-CoV neutralising antibody titres varied between 1/320 and 1/2560 for the Omani camel sera and between 1/20 and 1/320 for the Spanish camel sera. There was no evidence for cross-neutralisation by bovine coronavirus antibodies. Interpretation: MERS-CoV or a related virus has infected camel populations. Both titres and seroprevalences in sera from different locations in Oman suggest widespread infection. Funding: European Union, European Centre For Disease Prevention and Control, Deutsche Forschungsgemeinschaft.
UR - http://www.scopus.com/inward/record.url?scp=84884377173&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84884377173&partnerID=8YFLogxK
U2 - 10.1016/S1473-3099(13)70164-6
DO - 10.1016/S1473-3099(13)70164-6
M3 - Article
C2 - 23933067
AN - SCOPUS:84884377173
SN - 1473-3099
VL - 13
SP - 859
EP - 866
JO - The Lancet Infectious Diseases
JF - The Lancet Infectious Diseases
IS - 10
ER -
